GWM
RAYC

Geneos Wealth Management’s Rayliant Quantamental China Equity ETF RAYC Stock Holding History

Geneos Wealth Management’s Portfolio RAYC Stock Details RAYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-700
Closed -$10.7K – 2136
2023
Q2 		$10.7K Hold
700
– – ﹤0.01% 1562
2023
Q1 		$12.1K Buy
+700
New +$12.7K ﹤0.01% 1497

Other funds holding RAYC

CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Geneos Wealth Management's RAYC Position: Q3 2023 in Review

Geneos Wealth Management sold out of Rayliant Quantamental China Equity ETF (RAYC) in Q3 2023, closing a stake of 700 shares — an estimated $10.7K sold.

Geneos Wealth Management first reported a position in RAYC in Q1 2023 and held it in 2 quarters. The position peaked at $12.1K in Q1 2023. 5 funds tracked by Wall St. Rank hold RAYC as of Q3 2023.

  • Geneos Wealth Management reported no remaining Rayliant Quantamental China Equity ETF position as of Q3 2023 after selling out during the quarter.
  • Geneos Wealth Management sold 700 Rayliant Quantamental China Equity ETF shares in Q3 2023, an estimated $10.7K.
  • Geneos Wealth Management first reported a position in Rayliant Quantamental China Equity ETF in Q1 2023 and held it in 2 quarters.
  • Geneos Wealth Management's Rayliant Quantamental China Equity ETF position peaked at $12.1K in Q1 2023.
  • 5 funds tracked by Wall St. Rank held Rayliant Quantamental China Equity ETF as of Q3 2023.

Based on Geneos Wealth Management's 13F filing for Q3 2023, filed 11 Oct 2023.